 et al., 1993, 1995 
Results

Generation of Transgenic Mice
Founder lines of transgenic mice were generated with the human a2, a5, and f3, integrin subunit cDNAs cloned into an involucrin expression cassette (containing the human involucrin promoter and intron; see Figure  1 ) described previously (Carroll et al., 1993 Figure  2a ) and also within the inner root sheath of the hair follicles, where the involucrin promoter has previously been shown to be active (Carroll et al., 1993 Note thickening of epidermis to right of field, with increased dermal cellularity underneath the thickened epidermis, (c) 0794 x 0869 a&, transgenic.
Small arrows, suprabasal epidermal mitoses; large arrows, dilated capillaries. (d) 1067 x 0840 a&, transgenic.
Curved arrow, pustule in parakeratotic cornified layers. Scale bar, 60 pm. A group of 41 mice from eight different litters of the 0840 5, founder line was observed three times a week for 12 weeks. During that time, 22 of the animals developed flaking of the skin; animals were affected for l-2 weeks and then went into remission. The number of episodes per animal during the observation period ranged from one to three. Occasional animals (not included in the group of 41) never went into remission. Affected animals within a given litter did not exhibit the phenotype synchronously. The incidence of flaking and inflammation was the same among males and females.
Epidermal Proliferation and Terminal Differentiation
The epidermis of adult mice expressing 5,, a&,, or a& was examined histologically for evidence of abnormal proliferation and differentiation ( Figure 5 ). Histopathological features were similar in the skin from 5,, a&,, or a& mice. Abnormal histology was focal in the epidermis and underlying dermis of mildly affected animals, but covered extensive areas of more severely affected mice. All biopsies were matched for age, sex, and body site, and transgenenegative littermates were compared whenever possible. Skin from all trunk sites showed abnormal histology, but skin from tail, ear tips, and cheek did not. Different trunk sites of a given animal could show varying severity of phenotype, but there was no correlation between site (e.g., back versus belly) and severity. Figure 5 shows hematoxylin-and eosin-stained sections of skin from the back of a normal mouse (Figure 5a ) and sections of transgenic mouse skin (Figures 5b-5d) . Figures 5b-5d have been chosen to show the variation in severity of epidermal hyperproliferation and inflammation. In mildly affected animals (Figure 5b ), epidermal thickening was often observed adjacent to a relatively unaffected area; in the dermis directly below the thickened epidermis, an increased cellularity was apparent. In more severely affected animals (Figure 5c ), there was widespread thickening (hyperplasia) of the epidermis, reflecting both an increase in the number of viable cell layers (acanthosis) and cornified layers (hyperkeratosis). There were alternating regions of anucleate (orthokeratotic) and nucleated (parakeratotic) cornified cells, the underlying granular layer being absent in regions of parakeratosis. In the most severe phenotype, there were neutrophilcontaining pustules within or beneath the cornified layers and large numbers of lymphocytes and polymorphs within the epidermis (Figure 5d ). Dermal involvement was widespread in the intermediate and severely affected mice and was characterized by infiltration of lymphocytes and neutrophils into the dermis, dermal mitoses, and dilated capillaries (Figures 5c and 5d ). Using the TdT-mediated dUTPbiotin nickend-labeling (TUNEL) technique, we found that there were no major differences in the number of keratinocytes with apoptotic nuclei in normal or in mildly or severely affected epidermis (data not shown). Figure  7h ). CDCpositive cells were present in the epidermis and der-mis ( Figure 7e ). intense focal staining for ICAM-was observed in all layers of the epidermis and in the underlying dermis (Figure 7k ). In the most severely affected mice, there were many more CD&positive lymphocytes in the epidermis than found in mildly affected animals (compare Figures 7h and  7i) , and the number of CD4-positive cells in the dermis was also increased (compare Figures 7e and 7f ). There were numerous CD3-positive cells in the epidermis and dermis ( Figure 7~ ). ICAM-staining was less intense but more extensive in the severe lesions (Figure 71 ) than in mildly affected epidermis (Figure 7k ).
Discussion
Strong evidence for a role of integrins in disease has come from the identification of integrin gene mutations in inheriteddisorders(see, e.g., Wardlawetal., 1990)andfromthe efficacy of integrin antagonists in the treatment of some cancers and cardiovascular disease (see, e.g., Brooks et al., 1994) . Nevertheless, there is a much wider range of conditions that are correlated with abnormal integrin expression or function, but for which a direct link with pathogenesis is lacking. We and others have noted that suprabasal integrin expression is commonly seen in situations in which keratinocytes are hyperproliferative (reviewed by Watt and Hertle, 1994); our transgenic model now demonstrates that this relationship is causal.
The involucrin promoter is active in keratinocytes during eyelid and hair follicle development (J. M. C. and F. M. W., unpublished data), and the as, PI, and a& transgenic mice had defects in those structures (failure of eyelid fusion and disorganized follicles) that were strikingly similar to those of animals containing mutations or disruptions in the genes encoding transforming growth factor a (TGFa) (Luetteke et al., 1993; Mann et al., 1993 ) the epidermal growth factor (EGF) receptor (Luetteke et al., 1994) , the activinlinhibin (38 subunit (Vassalli et al., 1994) , or cab/ (Schwartzberg et al., 1991) . The similarities between the integrin mice and mice with disrupted growth factor signaling pathways may be more than coincidental because growth factors are known to regulate integrin levels in keratinocytes (see, e.g., Zambruno et al., 1995) . We therefore speculate that specific growth factors may be regulating the temporal and spatial patterns of integrin expression in keratinocytes during development and that perturbation of the growth factor signaling pathways or of integrin expression will therefore result in similar developmental abnormalities. Furthermore, the association of eyelid and hair follicle defects with misexpression of the a5 subunit, but not the a2 subunit, argues for specificity of integrin function in developing epithelia.
Psoriasis is a common human skin disease that is characterized by increased keratinocyte proliferation, abnormal differentiation, and inflammation of the dermis and epidermis (Krueger et al., 1984) . Adult transgenic mice expressing the 8, transgene, alone or in combination with a2 or a5, had many features reminiscent of adult chronic plaque psoriasis, specifically psoriasis vulgaris. In humans and these transgenic mice, the early changes include increased proliferation of basal keratinocytes, hyperkeratosis (i.e., increased number of cornified cells), increased dermal mitoses and capillary dilation, and an influx of CD4-positive and CD8-positive T lymphocytes. More severe lesions are characterized by severe hyperplasia (thickening of the epidermis), regions of parakeratosis with loss of underlying granular cells, and large numbersof epidermal CD&positive cells and of dermal CDCpositive cells. In the mice, neutrophil-laden pustules similar to the Munro microabscesses of psoriasis vulgaris were commonly observed. As in psoriasis, there was induction of ICAM-and an increase in Ki-67 labeling (see Paukkonen et al., 1995) ; K6 was induced in the interfollicular epidermis, and the level of Kl was decreased (see Stoler et al., 1988) . The only major feature of psoriasis not reproduced in the mice was elongation of the rete ridges, but since the dermoepidermal junction in normal mice is flat (i.e., lacking rete ridges), this is not surprising. Other interesting parallels with the mice are the frequent lack of psoriasis development before adulthood, the waxing and waning of the disease, and the variation in phenotype with body site (Krueger and Duvic, 1994) . Psoriasis is also believed to have genetic and environmental components (Krueger and Duvic, 1994), and we speculate that this could explain the degree of penetrance of the phenotype in our mice, which have a mixed genetic background. Other animal models (transgenic or spontaneous mutants) have some features of psoriasis, but none share as many characteristics of the disease as the integrin transgenics (see Leonard et al., 1988; Wilson et al., 1990; Hammer et al., 1990; Vassar and Fuchs, 1991; Dominey et al., 1993; Sundberg et al., 1993) .
In the transgenic mice expressing j3,, a&, or a&, there were keratinocyte hyperproliferation and abnormal terminal differentiation and an immune response in the skin. While the need to sacrifice animals for histology made it impossible to follow the evolution of individual lesions, Ki-67 labeling showed that there could be keratinocyte hyperproliferation in the absence of an inflammatory infiltrate ( Figure 6b) ; in contrast, we never saw inflammation without keratinocyte hyperproliferation and abnormal differentiation. This strongly suggests that the primary cause of the psoriasiform phenotype in these mice is the effect of abnormal integrin expression on the keratinocytes.
How does suprabasal integrin expression trigger hyperproliferation?
The mechanism may depend on the functional status of the receptors. 8, integrins in keratinocytes can exist in an active (high affinity for ligand) or inactive (low ligand binding affinity) state, the transition between the two states being reversible (Hotchin et al., 1993) . Although the transgenic a& integrin bound to fibronectin in adhesion assays of cultured keratinocytes, we do not know the activation state of the transgenic receptors in vivo. They might be inactive, as a result of the absence of suprabasal type IV collagen and fibronectin ligands (see Hotchin et al., 1993) , or they might have a nonmatrix binding role, for example, in intercellular adhesion (see Symington et al., 1993 et al., 1993) .
Experimental Procedures
Transgene Construction lntegrin cDNAs were cloned into the Not1 site of an involucrin expression cassette consisting of 2.5 kb of the human involucrin upstream region, the involucrin intron, an SV40 intron, and an SV40 polyadenylation sequence (Figure 1 ; Carroll et al., 1993) . The cDNA for human czz integrin was excised from the plasmid pJ7(provided by F. Berdishevsky and J. Taylor-Papadimitriou, Imperial Cancer Research Fund) as an Xbal-Kpnl fragment, blunt ended, and ligated to Not1 linkers. The human a5 cDNA was excised from the pECE plasmid as a Sall-Xbal fragment, blunt ended, and ligated to Notl linkers, and the human p, cDNA was excised from pECE as an EcoRl fragment, blunt ended, and ligated to Notl linkers (a, and 8, plasmids were provided by E. Ruoslahti, La Jolla Cancer Research Center: Giancotti and Ruoslahti, 1990) . All transgenes were excised from the parent plasmids as Sall fragments, purified as described previously (Carroll et al., 1993) , and resuspended in sterile PBS at a concentration of 5 pglml for oocyte injection.
Preparation of Transgenic
Mice Animals were screened for the presence of transgenes using PCR of ear DNAwith primers specific for the transgenes (one primer specific for the SV40 intron in each transgene, the other specific for the 5'end of each integrin cDNA). As an initial screen of transgene expression, total RNA was isolated from the skin, heart, and liver of control and transgene-positive animals; RT-PCR was then carried out as described previously (Carroll et al., 1993) with transgene-specific and actin primers.
To determine transgene copy number, we isolated genomic DNA from mouse tail snips and digested the DNA with restriction enzymes excising a large piece of each respective transgenic DNA. Digests were electrophoresed on 1% agarose gels, blotted onto nylon, and probed with a human involucrin DNA probe consisting of a 1.4 kb Sac1 fragment of the involucrin upstream region. Copy numbers were determined as previously described (Carroll et al., 1993) , except that an IL-2 receptor probe (single copy gene; probe provided by M. Owen, Imperial Cancer Research Fund) was used to control for loading.
Histology, Immunofluorescence, and In Situ Hybridization Tissues from transgenic and transgene-negative mice matched according to sex and body site were used for all tissue studies. For histolpgical analysis, tissues were fixed overnight in formol-saline, embedded in paraffin, sectioned, and stained with hematoxylin and eosin. Chloroacetate esterase was used as a histochemical marker for neutrophils.
TUNEL was performed essentially as described by Gavrieli et al. (1992) on paraffin sections of normal and transgenic mice. In situ hybridization was performed essentially as described by Stoler et al. (1988) , using paraformaldhyde-fixed, paraffin-embedded sections of mouse skin. The probes were all ?S-labeled human integrin specific riboprobes (from pGEM4 integrin cDNA plasmids), approximately 500 bp in length. Sense probes were always used as controls.
For immunofluorescence studies, mouse tissues were placed in OCT and snap frozen in an isopentane bath cooled with liquid nitrogen. Frozen sections of 8 urn thickness were cut on a cryostat. Sections were stained essentially as described previously (Hertle et al., 1992) (1994) . In brief, adult mice were killed by CO, asphyxiation, shaved, and sequentially dipped in povidone iodine solution (0.75% stock solution, diluted I:10 in distilled water), distilled water, and 70% ethanol. The skin was removed, rinsed thoroughly in PBS containing 100 UI ml penicillin, 100 uglml streptomycin, and 100 U/ml nystatin, and placed in 0.25% trypsin for 2-3 hr at 32OC. The epidermis wasscraped from the dermis and stirred in calcium-free FAD (one part Ham's F12, three parts DMEM, 1.8 x 10e4 M adenine, 200 U/ml penicillin, 200 pg/ ml streptomycin) containing 10% FCS for 20 min at room temperature. Cells were filtered through a 70 pm Teflon mesh, centrifuged, and resuspended in culture medium. Cells were then seeded onto vitrogen-fibronectin-coated dishes (Morris, 1994) . Two types of culture medium were used: SPRD-111, which is a fully defined high calcium medium (Morris, 1994) or calcium-freeMEM containing 8% Chelex-treated FCS. The MEM was supplemented as described by Miller et al. (1987) , except that 100 U/ml penicillin and 100 Kg/ml streptomycin were used instead of gentamycin. Brooks, P.C., Montgomery, A.M.P., Rosenfeld, M., Reisfeld, R.A., Hu, T., Klier, G., and Cheresh, D.A. (1994) . lntegrin a& antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-I 164.
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